Two critical tools to support TB affected communities launched

Two new tools to support TB affected communities and national TB programs, the TB Stigma Assessment Tool and The Right to Breathe: Human rights training for people with and affected by TB, are now available online.

Read More →

An Activist's Guide to the TB LAM Test

Treatment Action Group releases an updated version of its Activist’s Guide to the LAM Test with a complementary resource that tracks the status of LAM uptake in the 30 high TB/HIV burden countries.

Read More →

TB Valentine's Day Campaign

In anticipation of Valentine’s Day, the Stop TB Partnership launches an online campaign to celebrate love for all those affected by TB.

Read More →

Sanofi withdraws two patent applications on life-saving TB prevention drugs in Europe and in Indonesia

Activists urge Sanofi to do the same in other countries.

Read More →

MSF calls on Johnson & Johnson to lower price of lifesaving TB drug

Group protests at New York Stock Exchange as Johnson & Johnson releases earnings report.

Read More →

Lack of new antibiotics threatens global efforts to contain drug-resistant infections

Two new reports of the World Health Organization reveal a weak pipeline for antibiotic agents.

Read More →

TB Alliance responds to questions raised by activists in relation to pretomanid

MSF, TAG and TB CAB raised a number of outstanding medical and research questions regarding pretomanid and the regimen BPaL.

Read More →

WHO announces changes to the treatment of drug-resistant TB

WHO releases a Rapid Communication in advance of the updated guidelines for the treatment of drug-resistant TB expected in 2020.

Read More →

New TAG report: Funding for TB research climbed to new high in 2018

The report — Tuberculosis Research Funding Trends, 2005–2018 — presents new data on funding for TB research and development in 2018 and analyzes trends in spending since 2005.

Read More →

Stop TB Partnership launches the updated Global Plan to End TB 2018-2022

The updated Global Plan calls for 2.6 billion USD per year for vital research and development of new TB diagnostic tools, new drug regimens and a new vaccine, and 13 billion USD per year for TB care and prevention.

Read More →

Page 4 of 106 · Total posts: 10

←First 3 4 5 Last→